4 ms·
You’re probably right about the demand. Our population is higher now, and there’s the microdosing trend to account for, but it’s certainly not in the public co
by filoeleven 6y ago
You’re probably right about the demand. Our population is higher now, and there’s the microdosing trend to account for, but it’s certainly not in the public consciousness in the same way cannabis is—I’m almost as certain that that IS higher than ever.
I’m curious about your last statement. Scaling makes sense as a cost factor, but are you saying that lower barriers for production would increase the cost? That seems backwards to me.
- gverrilla 6y agoI perceive microdosing as a very fast dying fad, but it's only an opinion of course. About the cost, the way I understand it, the definitive factor is scalability. It's MUCH more scalable than the production of other drugs. If this was not the case, it probably would be VERY expensive, because of the very high barriers to entry and very low and distributed demand.